Prenatal maternal immune activation increases anxiety- and depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis

Neuroscience

Volumn 294, Issue , 2015, Pages 69-81

  Majidi Zolbanin, J ^a   Doosti, M H ^a   Kosari Nasab, M ^b   Salari, A A ^b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Anxiety; Depression; EAE; Maternal inflammation; Poly I:C; Sex differences

Indexed keywords

CORTICOSTERONE; POLYINOSINIC POLYCYTIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; ELEVATED PLUS MAZE TEST; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL DEPRESSION TEST; FEMALE; FORCED SWIM TEST; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMOBILITY; IMMUNIZATION; LATENT PERIOD; LIGHT DARK BOX TEST; MALE; MATERNAL DISEASE; MOUSE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; TAIL SUSPENSION TEST; ANIMAL; ANXIETY; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PREGNANCY;

ANIMALS; ANXIETY; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEPRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION; MALE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84925610117     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.03.016     Document Type: Article

References (92)

1. Abelson J.L., Curtis G.C. Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 1996, 53:323-331.
2. Amani M., Samadi H., Doosti M.-H., Azarfarin M., Bakhtiari A., Majidi-Zolbanin N., Mirza-Rahimi M., Salari A.-A. Neonatal NMDA receptor blockade alters anxiety-and depression-related behaviors in a sex-dependent manner in mice. Neuropharmacology 2013, 73:87-97.
3. Arnason B.G. Multiple sclerosis and depression: a neuroimmunological perspective. Neuroimmune Biol 2010, 9:269-307.
4. Babri S., Doosti M.-H., Salari A.-A. Strain-dependent effects of prenatal maternal immune activation on anxiety-and depression-like behaviors in offspring. Brain Behav Immun 2014, 37:164-176.
5. Babri S., Doosti M.-H., Salari A.-A. Tumor necrosis factor-alpha during neonatal brain development affects anxiety-and depression-related behaviors in adult male and female mice. Behav Brain Res 2014, 261:305-314.
6. Bale T.L., Baram T.Z., Brown A.S., Goldstein J.M., Insel T.R., McCarthy M.M., Nemeroff C.B., Reyes T.M., Simerly R.B., Susser E.S. Early life programming and neurodevelopmental disorders. Biol Psychiatry 2010, 68:314-319.
7. Bebo B.F., Schuster J.C., Vandenbark A.A., Offner H. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J Neurosci Res 1998, 52:420-426.
8. Beiske A., Svensson E., Sandanger I., Czujko B., Pedersen E., Aarseth J., Myhr K. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008, 15:239-245.
9. Bercik P., Verdu E.F., Foster J.A., Macri J., Potter M., Huang X., Malinowski P., Jackson W., Blennerhassett P., Neufeld K.A. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139(2102-2112):e2101.
10. Bergh F.T., Kümpfel T., Trenkwalder C., Rupprecht R., Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology 1999, 53. 772-777.
11. Brown R., Valpiani E., Tennant C., Dunn S., Sharrock M., Hodgkinson S., Pollard J. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother 2009, 82:41-56.
12. Cua D.J., Hinton D.R., Stohlman S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol 1995, 155:4052-4059.
13. Cui K., Ashdown H., Luheshi G.N., Boksa P. Effects of prenatal immune activation on hippocampal neurogenesis in the rat. Schizophr Res 2009, 113:288-297.
14. Cullinan W.E., Ziegler D.R., Herman J.P. Functional role of local GABAergic influences on the HPA axis. Brain Struct Funct 2008, 213:63-72.
15. Dahl O.P., Stordal E., Lydersen S., Midgard R. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County. Norway. Mult Scler 2009, 15:1495-1501.
16. Dalal M., Kim S., Voskuhl R.R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 1997, 159:3-6.
17. de Paiva V.N., Lima S.N., Fernandes M.M., Soncini R., Andrade C.A., Giusti-Paiva A. Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav Brain Res 2010, 215:146-151.
18. Del Giudice M. Fetal programming by maternal stress: insights from a conflict perspective. Psychoneuroendocrinology 2012, 37:1614-1629.
19. Doosti M.-H., Bakhtiari A., Zare P., Amani M., Majidi-Zolbanin N., Babri S., Salari A.-A. Impacts of early intervention with fluoxetine following early neonatal immune activation on depression-like behaviors and body weight in mice. Prog Neuropsychopharmacol Biol Psychiatry 2013, 43:55-65.
20. Enayati M., Solati J., Hosseini M.-H., Shahi H.-R., Saki G., Salari A.-A. Maternal infection during late pregnancy increases anxiety-and depression-like behaviors with increasing age in male offspring. Brain Res Bull 2012, 87:295-302.
21. Faa G., Marcialis M., Ravarino A., Piras M., Pintus M., Fanos V. Fetal programming of the human brain: is there a link with insurgence of neurodegenerative disorders in adulthood?. Curr Med Chem 2014, 21:3854-3876.
22. Feinstein A. Multiple sclerosis and depression. Mult Scler J 2011, 17:1276-1281.
23. Feinstein A., O'connor P., Gray T., Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 1999, 5:323-326.
24. Fiore M., Probert L., Kollias G., Akassoglou K., Alleva E., Aloe L. Neurobehavioral alterations in developing transgenic mice expressing TNF-α in the brain. Brain Behav Immun 1996, 10:126-138.
25. Fiore M., Alleva E., Probert L., Kollias G., Angelucci F., Aloe L. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-α. Physiol Behav 1998, 63:571-576.
26. Garay P.A., Hsiao E.Y., Patterson P.H., McAllister A. Maternal immune activation causes age-and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 2013, 31:54-68.
27. Giordano A., Granella F., Lugaresi A., Martinelli V., Trojano M., Confalonieri P., Radice D., Solari A. Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci 2011, 307:86-91.
28. Golan H., Levav T., Mendelsohn A., Huleihel M. Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb Cortex 2004, 14:97-105.
29. Gold S.M., Raji A., Huitinga I., Wiedemann K., Schulz K.-H., Heesen C. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis. J Neuroimmunol 2005, 165:186-191.
30. Gold S.M., Kern K.C., O'Connor M.-F., Montag M.J., Kim A., Yoo Y.S., Giesser B.S., Sicotte N.L. Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry 2010, 68:553-559.
31. Gold S.M., Krüger S., Ziegler K.J., Krieger T., Schulz K.-H., Otte C., Heesen C. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J Neurol Neurosurg Psychiatry 2011, 82:814-818.
32. Gross C., Hen R. The developmental origins of anxiety. Nat Rev Neurosci 2004, 5:545-552.
33. Haji N., Mandolesi G., Gentile A., Sacchetti L., Fresegna D., Rossi S., Musella A., Sepman H., Motta C., Studer V. TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol 2012, 237:296-303.
34. Handel A.E., Giovannoni G., Ebers G.C., Ramagopalan S.V. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010, 6:156-166.
35. Harbo H.F., Gold R., Tintoré M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord 2013, 6:237-248.
36. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacol 2011, 37:137-162.
37. Harvey L., Boksa P. Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev Neurobiol 2012, 72:1335-1348.
38. Heesen C., Gold S.M., Raji A., Wiedemann K., Schulz K.-H. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis. Psychoneuroendocrinology 2002, 27:505-517.
39. Heesen C., Gold S., Huitinga I., Reul J. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis-a review. Psychoneuroendocrinology 2007, 32:604-618.
40. Henn F.A., Vollmayr B. Neurogenesis and depression: etiology or epiphenomenon?. Biol Psychiatry 2004, 56:146-150.
41. Hsiao E.Y., Patterson P.H. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011, 25:604-615.
42. Imitola J., Chitnis T., Khoury S.J. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther 2005, 106:163-177.
43. Iosif R.E., Ekdahl C.T., Ahlenius H., Pronk C.J., Bonde S., Kokaia Z., Jacobsen S.-E.W., Lindvall O. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci 2006, 26:9703-9712.
44. Ito H.T., Smith S.E., Hsiao E., Patterson P.H. Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring. Brain Behav Immun 2010, 24:930-941.
45. Kaster M.P., Gadotti V.M., Calixto J.B., Santos A.R., Rodrigues A.L.S. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology 2012, 62:419-426.
46. Kellner M., Wiedemann K. Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy. Eur J Pharmacol 2008, 583:372-378.
47. Keohane A., Ryan S., Maloney E., Sullivan A.M., Nolan Y.M. Tumour necrosis factor-α impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: role of Hes1. Mol Cell Neurosci 2010, 43:127-135.
48. Khan D., Fernando P., Cicvaric A., Berger A., Pollak A., Monje F., Pollak D. Long-term effects of maternal immune activation on depression-like behavior in the mouse. Transl Psychiatry 2014, 4:e363.
49. Koolschijn P., van Haren N.E., Lensvelt-Mulders G.J., Pol H., Hilleke E., Kahn R.S. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 2009, 30:3719-3735.
50. Korostil M., Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007, 13:67-72.
51. Krishnan R., Cella D., Leonardi C., Papp K., Gottlieb A., Dunn M., Chiou C., Patel V., Jahreis A. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol 2007, 157:1275-1277.
52. Lesch K.P. Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci 2004, 29:174-184.
53. Majidi-Zolbanin J., Azarfarin M., Samadi H., Enayati M., Salari A.-A. Adolescent fluoxetine treatment decreases the effects of neonatal immune activation on anxiety-like behavior in mice. Behav Brain Res 2013, 250:123-132.
54. Majidi-Zolbanin J., Doosti M., Baradaran B., Amani M., Azarfarin M., Salari A. Neonatal immune activation during early and late postnatal brain development differently influences depression-related behaviors in adolescent and adult C57BL/6 mice. Neuroimmunol Neuroinflamm 2014, 1:35-39.
55. Makinodan M., Tatsumi K., Manabe T., Yamauchi T., Makinodan E., Matsuyoshi H., Shimoda S., Noriyama Y., Kishimoto T., Wanaka A. Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 2008, 86:2190-2200.
56. Mandal M., Donnelly R., Elkabes S., Zhang P., Davini D., David B.T., Ponzio N.M. Maternal immune stimulation during pregnancy shapes the immunological phenotype of offspring. Brain Behav Immun 2013, 33:33-45.
57. McCoy M.K., Tansey M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflamm 2008, 5:45.
58. McEwen B.S. Stress and hippocampal plasticity. Ann Rev Neurosci 1999, 22:105-122.
59. Mikova O., Yakimova R., Bosmans E., Kenis G., Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001, 11:203-208.
60. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
61. Mohr D.C., Hart S.L., Julian L., Cox D., Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004, 328:731.
62. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 2008, 583:115-127.
63. Noy S., Achiron A., Gabbay U., Barak Y., Rotstein Z., Laor N., Sarova-Pinhas I. A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry 1995, 36:390-395.
64. Oh-Nishi A., Obayashi S., Sugihara I., Minamimoto T., Suhara T. Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring. Brain Res 2010, 1363:170-179.
65. Okuda Y., Okuda M., Bernard C.C. Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol Lett 2002, 81:25-29.
66. Papenfuss T.L., Rogers C.J., Gienapp I., Yurrita M., McClain M., Damico N., Valo J., Song F., Whitacre C.C. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol 2004, 150:59-69.
67. Peruga I., Hartwig S., Thöne J., Hovemann B., Gold R., Juckel G., Linker R.A. Inflammation modulates anxiety in an animal model of multiple sclerosis. Behav Brain Res 2011, 220:20-29.
68. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
69. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000, 57:925-935.
70. Schumann E.M., Kümpfel T., Then Bergh F., Trenkwalder C., Holsboer F., Auer D.P. Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume. Ann Neurol 2002, 51:763-767.
71. Schwendener S., Meyer U., Feldon J. Deficient maternal care resulting from immunological stress during pregnancy is associated with a sex-dependent enhancement of conditioned fear in the offspring. J Neurodev Disord 2009, 1:15-32.
72. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003, 23:297-302.
73. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007, 27:10695-10702.
74. Soczynska J.K., Kennedy S.H., Goldstein B.I., Lachowski A., Woldeyohannes H.O., McIntyre R.S. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?. Neurotoxicology 2009, 30:497-521.
75. Solati J., Salari A. Involvement of dorsal hippocampal NMDA-glutamatergic system in anxiety-related behaviors of rats. Neurochem J 2011, 5:194-199.
76. Solati J., Asiaei M., Hoseini M.H.M. Using experimental autoimmune encephalomyelitis as a model to study the effect of prenatal stress on fetal programming. Neurol Res 2012, 34:478-483.
77. Stenager E.N., Stenager E. Suicide and patients with neurologic diseases: methodologic problems. Arch Neurol 1992, 49:1296-1303.
78. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011, 73:114-126.
79. Tomassini V., Pozzilli C. Sex hormones, brain damage and clinical course of multiple sclerosis. J Neurol Sci 2009, 286:35-39.
80. Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., Lalla D., Woolley M., Jahreis A., Zitnik R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006, 367:29-35.
81. Voskuhl R. Sex differences in autoimmune diseases. Biol Sex Differ 2011, 2:1.
82. Voskuhl R.R., Gold S.M. Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 2012, 8:255-263.
83. Voskuhl R.R., Pitchekian-Halabi H., Mackenzie-Graham A., McFarland H.F., Raine C.S. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 1996, 39:724-733.
84. Wallin M.T., Wilken J.A., Turner A.P., Williams R.M., Kane R. Depression and multiple sclerosis: review of a lethal combination. J Rehabil Res Dev 2006, 43:45.
85. Wang H., Meng X.-H., Ning H., Zhao X.-F., Wang Q., Liu P., Zhang H., Zhang C., Chen G.-H., Xu D.-X. Age-and gender-dependent impairments of neurobehaviors in mice whose mothers were exposed to lipopolysaccharide during pregnancy. Toxicol Lett 2010, 192:245-251.
86. Wood B., Van der Mei I., Ponsonby A., Pittas F., Quinn S., Dwyer T., Lucas R., Taylor B. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler J 2012, 19:217-224.
87. Yamada K., Iida R., Miyamoto Y., Saito K., Sekikawa K., Seishima M., Nabeshima T. Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-α gene: implications for emotional behavior. J Neuroimmunol 2000, 111:131-138.
88. Young E.A., Abelson J.L., Cameron O.G. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry 2004, 56:113-120.
89. Ysrraelit M.C., Gaitán M.I., Lopez A.S., Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008, 71:1948-1954.
90. Zager A., Peron J.P., Mennecier G., Rodrigues S.C., Aloia T.P., Palermo-Neto J. Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring. Brain Behav Immun 2014, in press. 10.1016/j.bbi.2014.1007.1021.
91. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001, 15:199-226.
92. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacol 2003, 28:1778-1789.